This 2023 initiative by the US Army Medical Research and Development Command (MRDC) and Medical Technology Enterprise Consortium (MTEC) will renew efforts from previous projects while bringing original ideas and the latest technologies to the research. The goal is to bring measurable acceleration to clinical products through robust partnerships.
The team will focus on developing clinical therapies over the next 5 years in the areas of:
Craniofacial Regeneration
Extremity Regeneration
Genitourinary/
Lower abdomen
Skin and Wound Healing
On-Demand Blood
